Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
14/08/2026 13:39
BRIEF-Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update Aug 14 (Reuters) - Quince Therapeutics, Inc. QNCX.O:
QUINCE THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND CORPORATE UPDATE
Source text: ID:nGNXK9nnK
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges